Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Indivior Pharmaceuticals, Inc. (SUPN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Indivior Pharmaceuticals, Inc. (SUPN), most recent 12 months reported: revenue $1.37B, net income $450M, free cash flow $31M. From SEC filings. More on Indivior Pharmaceuticals, Inc.: Revenue · Profitability · Cash flow Others in Pharmaceutical Preparations: Alkermes plc. · INSMED INC · Phibro Animal Health Corporation · MADRIGAL PHARMACEUTICALS, INC. · PTC Therapeutics, Inc. · ACADIA PHARMACEUTICALS INC. · PRESTIGE CONSUMER HEALTHCARE INC. · ANI PHARMACEUTICALS, INC

Stock screener

Watchlist